FIASP Penfill 100 units/ml price in UAE

Overview

Welcome to Dwaey, specifically on FIASP Penfill 100 units/ml Solution for injection page.
This medicine contains an important and useful components, as it consists of Insulin aspart.
FIASP Penfill 100 units/ml is available in the market in concentration 100 units/ml and in the form of Solution for injection.

NOVO NORDISK A/S is the producer of FIASP Penfill 100 units/ml and it is imported from DENMARK, The most popular alternatives of FIASP Penfill 100 units/ml are listed downward .

Mode Of Action

Insulin aspart, a rapid-acting analog of human insulin, lowers blood glucose levels; it regulates carbohydrate, protein and fat metabolism by inhibiting hepatic glucose production and lipolysis, and enhancing peripheral glucose disposal.

Indication

Diabetes mellitus

Precaution

Pregnancy (insulin requirements tend to fall during the 1st trimester, increase during the 2nd and 3rd) and lactation. Caution with decreased insulin requirements: Diarrhea, nausea/vomiting, malabsorption, hypothyroidism, renal impairment, hepatic impairment Hypokalemia may occur Use with caution in renal and hepatic impairment (dosage requirements may be reduced) Caution with increased insulin requirements: Fever, hyperthyroidism, trauma, infection, surgery Lactation: Safe to use while breastfeeding

Side Effects

Allergic reactions. Injection site reaction
lipodystrophy
pruritus
rash
lipoatrophy
hypokalaemia
blurred vision. Hypoglycaemia
insulin resistance.

Contra indication

Hypoglycaemia. Hypersensitivity to any of the components.

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Interaction

Effects may be increased by: oral antidiabetic agents, ACE inhibitors, disopyramide, fibrates, fluoxetine, MAOIs, propoxyphene, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics. Effects may be decreased by: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents, isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, oral contraceptives, lithium. Signs of hypoglycaemia may be masked by beta-blockers, clonidine.